Summary
Datamonitor's Sepracor Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company's key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
Sepracor is a research based pharmaceutical company for treating and preventing human disease by discovering, developing and commercializing innovative pharmaceutical products. The company is headquartered in Marlborough, Massachusetts and employs about 2,277 people. The company recorded revenues of $1,225.2 million during the fiscal year ended December 2007, an increase of 3.6% over 2006. The increase was primarily due to strong sales performance of its marketed products such as Lunesta and Xopenex HFA during the year. Introduction of Brovana in April 2007 in the US market also contributed to the revenue growth in the fiscal 2007. The operating profit of the company was $22.5 million during fiscal year 2007, a decrease of 85.1% over 2006. The net profit was $58.3 million in fiscal year 2007, a decrease of 65.9% over 2006. http://phx.corporate-ir.net/phoenix.zhtml?c=90106&p=irol-newsArticle&ID=1113967&highlight=
Scope of the Report
- Provides all the crucial company information required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
- Data is supplemented with details on the company's history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
Reasons to Purchase
- Support sales activities by understanding your customers' businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors' business structure, strategy and prospects
- Obtain the most up to date company information available.
|
